Associations - EGFR L747P

EGFR L747P EGFR L747P	Non Small Cell Lung Cancer NSCLC	EGFR L747P EGFR L747P	Non Small Cell Lung Cancer NSCLC	afatinib Sensitive: C3 – Early Trials	afatinib Sensitive: C3 – Early Trials
EGFR L747P EGFR L747P	Lung Adenocarcinoma LUAD	EGFR L747P EGFR L747P	Lung Adenocarcinoma LUAD	afatinib Sensitive: C3 – Early Trials	afatinib Sensitive: C3 – Early Trials
EGFR L747P EGFR L747P	Lung Adenocarcinoma LUAD	EGFR L747P EGFR L747P	Lung Adenocarcinoma LUAD	gefitinib Sensitive: C4 – Case Studies	gefitinib Sensitive: C4 – Case Studies
EGFR L747P EGFR L747P	Lung Adenocarcinoma LUAD	EGFR L747P EGFR L747P	Lung Adenocarcinoma LUAD	osimertinib Sensitive: C4 – Case Studies	osimertinib Sensitive: C4 – Case Studies
EGFR L747P EGFR L747P	Non Small Cell Lung Cancer NSCLC	EGFR L747P EGFR L747P	Non Small Cell Lung Cancer NSCLC	gefitinib Resistant: C4 – Case Studies	gefitinib Resistant: C4 – Case Studies
EGFR L747P EGFR L747P	Lung Adenocarcinoma LUAD	EGFR L747P EGFR L747P	Lung Adenocarcinoma LUAD	erlotinib Sensitive: C4 – Case Studies	erlotinib Sensitive: C4 – Case Studies